Woolf NJ, Butcher LL (May 1986). "Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain". Brain Research Bulletin. 16 (5): 603–37. doi:10.1016/0361-9230(86)90134-6. PMID3742247. S2CID39665815.
Woolf NJ, Butcher LL (December 1989). "Cholinergic systems in the rat brain: IV. Descending projections of the pontomesencephalic tegmentum". Brain Research Bulletin. 23 (6): 519–40. doi:10.1016/0361-9230(89)90197-4. PMID2611694. S2CID4721282.
Zassler B, Dechant G, Humpel C (2005). "Urea enhances the nerve growth factor-induced neuroprotective effect on cholinergic neurons in organotypic rat brain slices". Neuroscience. 130 (2): 317–23. doi:10.1016/j.neuroscience.2004.09.010. PMID15664688. S2CID39832814.
Cuello AC, Bruno MA (June 2007). "The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer's disease". Neurochemical Research. 32 (6): 1041–5. doi:10.1007/s11064-006-9270-0. PMID17404842. S2CID130366.
Auld DS, Kornecook TJ, Bastianetto S, Quirion R (October 2002). "Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies". Progress in Neurobiology. 68 (3): 209–45. doi:10.1016/S0301-0082(02)00079-5. PMID12450488. S2CID53151403.
Fu AL, Li Q, Dong ZH, Huang SJ, Wang YX, Sun MJ (September 2004). "Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase". Neuroscience Letters. 368 (3): 258–62. doi:10.1016/j.neulet.2004.05.116. PMID15364407. S2CID23038763.
Woolf NJ, Butcher LL (May 1986). "Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain". Brain Research Bulletin. 16 (5): 603–37. doi:10.1016/0361-9230(86)90134-6. PMID3742247. S2CID39665815.
Woolf NJ, Butcher LL (December 1989). "Cholinergic systems in the rat brain: IV. Descending projections of the pontomesencephalic tegmentum". Brain Research Bulletin. 23 (6): 519–40. doi:10.1016/0361-9230(89)90197-4. PMID2611694. S2CID4721282.
Zassler B, Dechant G, Humpel C (2005). "Urea enhances the nerve growth factor-induced neuroprotective effect on cholinergic neurons in organotypic rat brain slices". Neuroscience. 130 (2): 317–23. doi:10.1016/j.neuroscience.2004.09.010. PMID15664688. S2CID39832814.
Cuello AC, Bruno MA (June 2007). "The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer's disease". Neurochemical Research. 32 (6): 1041–5. doi:10.1007/s11064-006-9270-0. PMID17404842. S2CID130366.
Auld DS, Kornecook TJ, Bastianetto S, Quirion R (October 2002). "Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies". Progress in Neurobiology. 68 (3): 209–45. doi:10.1016/S0301-0082(02)00079-5. PMID12450488. S2CID53151403.
Fu AL, Li Q, Dong ZH, Huang SJ, Wang YX, Sun MJ (September 2004). "Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase". Neuroscience Letters. 368 (3): 258–62. doi:10.1016/j.neulet.2004.05.116. PMID15364407. S2CID23038763.
Woolf NJ, Butcher LL (May 1986). "Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain". Brain Research Bulletin. 16 (5): 603–37. doi:10.1016/0361-9230(86)90134-6. PMID3742247. S2CID39665815.
Woolf NJ, Butcher LL (December 1989). "Cholinergic systems in the rat brain: IV. Descending projections of the pontomesencephalic tegmentum". Brain Research Bulletin. 23 (6): 519–40. doi:10.1016/0361-9230(89)90197-4. PMID2611694. S2CID4721282.
Zassler B, Dechant G, Humpel C (2005). "Urea enhances the nerve growth factor-induced neuroprotective effect on cholinergic neurons in organotypic rat brain slices". Neuroscience. 130 (2): 317–23. doi:10.1016/j.neuroscience.2004.09.010. PMID15664688. S2CID39832814.
Cuello AC, Bruno MA (June 2007). "The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer's disease". Neurochemical Research. 32 (6): 1041–5. doi:10.1007/s11064-006-9270-0. PMID17404842. S2CID130366.
Auld DS, Kornecook TJ, Bastianetto S, Quirion R (October 2002). "Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies". Progress in Neurobiology. 68 (3): 209–45. doi:10.1016/S0301-0082(02)00079-5. PMID12450488. S2CID53151403.
Fu AL, Li Q, Dong ZH, Huang SJ, Wang YX, Sun MJ (September 2004). "Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase". Neuroscience Letters. 368 (3): 258–62. doi:10.1016/j.neulet.2004.05.116. PMID15364407. S2CID23038763.